OMBITASVIR | OMBITASVIR | ATC J05AX67 ATC J05AP53
ANTIINFECTIVES TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) HEPATITIS C VIRUS NS5A INHIBITOR | ORAL | Cmax 76.1 NANOMOLAR Tmax 4.5 HOUR F 48.1 PERCENT VD 50.1 LITER PPB 99.9 PERCENT Cl 1.5 LITER / HOUR (EQN) HT 23 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN AQUEOUS BUFFERS | HCV NS5A | NONSTRUCTURAL PROTEIN 5A INHIBITOR CHEMBL3307224 NONSTRUCTURAL PROTEIN 5A Q5L478 NONSTRUCTURAL PROTEIN 5A HEPATITIS C VIRUS UNCLASSIFIED | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |